This is EMKases, EM Quick Hits podcast.

Quick. Let's get on with it.

EM cases is part of Shremi, the Schwartz-Riseman Emergency Medicine Institute.

That's the nonprofit organization dedicated to improving EM care through high-quality research and education. The opinions expressed on this podcast are intended for general information and educational purposes only and should not be used to diagnose treat or prevent any medical condition, nor should they be used as a substitute for medical advice from qualified practicing physician. Unless stated otherwise, the opinions expressed by the hosts or guests are made in their individual capacity, not on behalf of the Institute nor Medicine Cases.

This episode is brought to you by Easy Resus, your ultimate support for the first hour of resuscitation.

This amazing phone app has drug dosing treatment algorithms and procedural aids all

in under three clicks.

Rapid access to life-saving critical info in a user-friendly interface.

Try the app for free with the promo code EMCases or visit easy recess.com slash EM cases.

That's the letter is easy recess.com slash EM cases.

All right, to kick off this EM quick hits.

Swami is going to give us an update on induction agents.

Now, as you're listening, think about which airway situations you'd reach for ketamine

versus propofal versus atomitate and why.

EM clinicians love a good airway argument.

We've got the ongoing video versus direct laryngoscopy discussion,

bougie first, we've got Rock versus Sucks, just to name a few,

and induction agents are another area with a lot of impassioned discussion

on which drug is best and what dose we should be using.

The most common agents that we are reaching for are Atomidate, Ketamine, and Propopal. I'm not even going to discuss Madazelam. It's truly a

subpar agent when compared to the other three, and honestly, I haven't used it in close to 20 years.

Atomidate has been the darling agent in EM for most of my career, and I think there's a good

...